| Product Code: ETC7544936 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Heart Failure Diagnostics/Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Heart Failure Diagnostics/Therapeutics Market - Industry Life Cycle |
3.4 India Heart Failure Diagnostics/Therapeutics Market - Porter's Five Forces |
3.5 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Tests, 2021 & 2031F |
4 India Heart Failure Diagnostics/Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of heart failure in India |
4.2.2 Growing awareness and focus on preventive healthcare measures |
4.2.3 Technological advancements in diagnostics and therapeutics for heart failure |
4.3 Market Restraints |
4.3.1 High cost associated with heart failure diagnostics and therapeutics |
4.3.2 Limited access to specialized healthcare facilities in certain regions of India |
5 India Heart Failure Diagnostics/Therapeutics Market Trends |
6 India Heart Failure Diagnostics/Therapeutics Market, By Types |
6.1 India Heart Failure Diagnostics/Therapeutics Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Resynchronization Therapy, 2021- 2031F |
6.1.4 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Ventricular Assist Devices, 2021- 2031F |
6.1.5 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Counterpulsation Implants, 2021- 2031F |
6.1.6 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Heart Failure Surgery, 2021- 2031F |
6.1.7 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Fluid Reduction (Renal Impairment), 2021- 2031F |
6.1.8 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Neurostimulation, 2021- 2031F |
6.1.9 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.1.10 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.2 India Heart Failure Diagnostics/Therapeutics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By ECG Systems, 2021- 2031F |
6.2.3 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Holter Monitors, 2021- 2031F |
6.2.4 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Event Monitors, 2021- 2031F |
6.2.5 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Implantable Loop Recorders, 2021- 2031F |
6.3 India Heart Failure Diagnostics/Therapeutics Market, By Tests |
6.3.1 Overview and Analysis |
6.3.2 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.3.3 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Chest X Ray, 2021- 2031F |
6.3.4 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Electrocardiogram, 2021- 2031F |
6.3.5 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.3.6 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Stress Test, 2021- 2031F |
6.3.7 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging, 2021- 2031F |
6.3.8 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
6.3.9 India Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
7 India Heart Failure Diagnostics/Therapeutics Market Import-Export Trade Statistics |
7.1 India Heart Failure Diagnostics/Therapeutics Market Export to Major Countries |
7.2 India Heart Failure Diagnostics/Therapeutics Market Imports from Major Countries |
8 India Heart Failure Diagnostics/Therapeutics Market Key Performance Indicators |
8.1 Adoption rate of advanced diagnostic technologies for heart failure |
8.2 Percentage of heart failure patients under proper treatment and management |
8.3 Number of healthcare facilities offering specialized services for heart failure |
9 India Heart Failure Diagnostics/Therapeutics Market - Opportunity Assessment |
9.1 India Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 India Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 India Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Tests, 2021 & 2031F |
10 India Heart Failure Diagnostics/Therapeutics Market - Competitive Landscape |
10.1 India Heart Failure Diagnostics/Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Heart Failure Diagnostics/Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here